I

Integer Holdings Corp
NYSE:ITGR

Watchlist Manager
Integer Holdings Corp
NYSE:ITGR
Watchlist
Price: 134.75 USD 0.8% Market Closed
Market Cap: 4.5B USD
Have any thoughts about
Integer Holdings Corp?
Write Note

Integer Holdings Corp
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Integer Holdings Corp
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
I
Integer Holdings Corp
NYSE:ITGR
Net Income (Common)
$134.1m
CAGR 3-Years
15%
CAGR 5-Years
4%
CAGR 10-Years
10%
Becton Dickinson and Co
NYSE:BDX
Net Income (Common)
$1.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Net Income (Common)
$1.8B
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
20%
Stryker Corp
NYSE:SYK
Net Income (Common)
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
Net Income (Common)
$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income (Common)
$2.2B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
18%
No Stocks Found

Integer Holdings Corp
Glance View

Market Cap
4.5B USD
Industry
Health Care

Integer Holdings Corporation, a prominent player in the medical device industry, has carved a significant niche by aligning innovation with robust manufacturing capabilities. Founded as a collaborative effort between technical ingenuity and healthcare innovation, Integer primarily engages in the design and production of medical devices and components that are instrumental for the med-tech sector. It serves a diverse clientele that ranges from large healthcare conglomerates to emerging med-tech companies. The company operates through two main segments: Medical and Non-Medical. In the Medical division, Integer excels by providing critical components used in cardiac rhythm management, neuromodulation, and vascular access. It thrives on the premise that precision in manufacturing and innovation are key to producing reliable and effective medical solutions, ensuring that they meet stringent regulatory standards. What truly propels Integer’s financial engine is its commitment to operational excellence and strategic partnerships. By integrating vertically across its production processes, Integer achieves cost efficiencies that allow it to offer competitive pricing without sacrificing quality. Moreover, the company extends its influence through strategic partnerships with prominent healthcare providers, thereby securing long-term contracts and steady revenue streams. This model is supplemented by its Non-Medical segment, where Integer provides high-reliability components for energy, military, and environmental applications. These ventures not only diversify its revenue portfolio but also bolster its resilience against market volatility. Integer’s growth narrative is underscored by a relentless focus on research and development, which facilitates continuous product enhancement and keeps it at the forefront of technological advancement in the medical device industry. Through these strategies, Integer Holdings Corporation not only sustains its market position but also expands its role as a critical enabler in the global healthcare landscape.

ITGR Intrinsic Value
133.27 USD
Overvaluation 1%
Intrinsic Value
Price
I

See Also

What is Integer Holdings Corp's Net Income (Common)?
Net Income (Common)
134.1m USD

Based on the financial report for Sep 27, 2024, Integer Holdings Corp's Net Income (Common) amounts to 134.1m USD.

What is Integer Holdings Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
10%

Over the last year, the Net Income (Common) growth was 62%. The average annual Net Income (Common) growth rates for Integer Holdings Corp have been 15% over the past three years , 4% over the past five years , and 10% over the past ten years .

Back to Top